Good afternoon :)
Place Order
Add to Watchlist

CARE Ratings Ltd

CARERATING

CARE Ratings Ltd

CARERATING
FinancialsStock Exchanges & Ratings
SmallcapWith a market cap of ₹4,291 cr, stock is ranked 840
Moderate RiskStock is 2.80x as volatile as Nifty
1,418.101.72% (-24.75)
1,418.101.72% (-24.75)

Price Chart

High
—
Low
—
Returns
—
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
FinancialsStock Exchanges & Ratings
SmallcapWith a market cap of ₹4,291 cr, stock is ranked 840
Moderate RiskStock is 2.80x as volatile as Nifty

How to use scorecard? Learn more

FinancialsStock Exchanges & Ratings
SmallcapWith a market cap of ₹4,291 cr, stock is ranked 840
Moderate RiskStock is 2.80x as volatile as Nifty

Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
37.525.921.25%
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
18.342.550.94%

Forecast & Ratings

Detailed Forecast 
100%
Analysts have suggested that investors can buy this stock

from 1 analyst

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Credit Analysis and Research Limited is a credit rating agency. The Company's segments include Ratings and related services, and Others.

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

Forecasts

Price

Revenue

Earnings

Income

Balance Sheet

Cash Flow

Income Statement

Industry refers to the sub-sector this company belongs to.

Lower than Industry Revenue Growth

A higher-than-industry revenue growth represents increased potential for the company to increase their market share

Over the last 5 years, revenue has grown at a yearly rate of 1.61%, vs industry avg of 17.42%

Decreasing Market Share

Market share is the percentage of an industry's total sales going to a particular company. It gives a general idea of the size of a company v/s its competitors

Over the last 5 years, market share decreased from 8.97% to 8.1%

Lower than Industry Net Income

Net income is equal to net earnings (profit) less expenses. This number is an important measure of how profitable the company is

Over the last 5 years, net income has grown at a yearly rate of -6.07%, vs industry avg of 16.9%

Loading...

Financial YearFY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024TTM
Total Revenue288.06321.10358.15349.36275.11279.74274.82316.93378.37412.82
Raw Materialssubtract0.000.000.000.000.000.000.000.000.00235.18
Power & Fuel Costsubtract1.321.181.231.251.330.940.811.151.17
Employee Costsubtract75.6372.6088.91102.81109.27119.86126.41133.94164.58
Selling & Administrative Expensessubtract21.4020.7525.1926.7028.5722.2628.3932.0037.38
Operating & Other expensessubtract7.1410.696.5913.5423.159.6112.4112.5616.42
Depreciation/Amortizationsubtract4.173.393.153.337.777.807.7110.5310.4810.92
Interest & Other Itemssubtract0.000.000.000.000.930.620.461.001.711.88
Taxes & Other Itemssubtract58.7964.8470.6764.2621.7229.1323.5242.2246.1150.46
EPS40.9650.1855.1446.6627.9630.3925.4128.1533.7638.32
DPS28.0028.0055.0030.0019.5017.0017.0025.0018.0018.00
Payout ratio0.680.561.000.640.700.560.670.890.530.47

Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange
FY 2021

Annual report

PDF

Investor Presentation

Jun 13PDF
FY 2022

Annual report

PDF

Investor Presentation

May 29PDF
Jan 28PDF
Oct 29PDF
Aug 4PDF
FY 2023

Annual report

PDF

Investor Presentation

May 11PDF
Jan 28PDF
Dec 14PDF
Nov 8PDF
FY 2024

Annual Report Pending

Investor Presentation

Aug 9PDF
 

Peers & Comparison

Comparing 3 stocks from 
FinancialsStock Exchanges & Ratings

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
CARE Ratings Ltd42.705.921.25%
BSE Ltd79.5217.920.33%
CRISIL Ltd59.6317.931.01%
Central Depository Services (India) Ltd85.7023.830.64%

Price Comparison

Compare CARERATING with any stock or ETF
Compare CARERATING with any stock or ETF
CARERATING
Loading...

Shareholdings

Promoter Holdings Trend

Total Promoter Holding

Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding

Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Institutional Holdings Trend

Total Retail Holding

Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.

In last 3 months, retail holding in the company has almost stayed constant

Increased Foreign Institutional Holding

Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock

In last 3 months, foreign institutional holding of the company has increased by 1.42%

Tickertape Separator

Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding0.00%10.64%14.64%24.80%49.93%

Dec 2023

Mar 2024

Jun 2024

Sep 2024

Shareholding History

JunSepDec '23MarJunSep20.26%20.90%21.67%22.91%23.37%24.80%

Mutual Funds Holding Trend

Mutual Fund Holding

Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

Top 5 Mutual Funds holding CARE Ratings Ltd




Funds (Top 5)Market-cap heldWeight3M holding changePortfolio rank
(3M change)
Nippon India Small Cap Fund - Growth - Direct Plan

Growth
5.2227%0.36%0.11%75/234 (+71)
Nippon India Multi Cap Fund - Growth - Direct Plan

Growth
3.2033%0.36%0.12%88/121 (+16)
Mirae Asset Multicap Fund - Growth - Direct Plan

Growth
1.4122%1.80%0.67%6/95 (+32)

Compare 3-month MF holding change on Screener

Insider Trades & Bulk Deals

Hmm, looks like there hasn't been any net deal activity in the last 6 months

smallcases

Looks like this stock is not in any smallcase yet.

Events

Dividend Trend

Dividend Yield

Dividend return is one of the most important things to be considered while investing for long term. It is the additional return on top of what investors earn through price appreciation

Current dividend yield is 1.25%. An investment of ₹1,000 in the stock is expected to generate dividend of ₹12.52 every year

Dividends

Corp. Actions

Announcements

Legal Orders

Upcoming Dividends

No upcoming dividends are available

Past Dividends

Cash Dividend

Ex DateEx DateNov 5, 2024

Interim
Interim | Div/Share: ₹7.00

Dividend/Share

₹7.00

Ex DateEx Date

Nov 5, 2024

Cash Dividend

Ex DateEx DateJun 21, 2024

Final
Final | Div/Share: ₹11.00

Dividend/Share

₹11.00

Ex DateEx Date

Jun 21, 2024

Cash Dividend

Ex DateEx DateNov 10, 2023

Interim
Interim | Div/Share: ₹7.00

Dividend/Share

₹7.00

Ex DateEx Date

Nov 10, 2023

Cash Dividend

Ex DateEx DateJul 7, 2023

Special
Special | Div/Share: ₹8.00

Dividend/Share

₹8.00

Ex DateEx Date

Jul 7, 2023

Cash Dividend

Ex DateEx DateJul 7, 2023

Final
Final | Div/Share: ₹7.00

Dividend/Share

₹7.00

Ex DateEx Date

Jul 7, 2023

News & Opinions
Spotlight
CARE Ratings freezes higher after strong Q2 outcome

On a consolidated basis, profit before tax (PBT) stood at Rs 64.23 crore in Q2 FY25, up 28.3% year-on-year (YoY). EBITDA rose 33% YoY to Rs 55.72 crore during the period under review. EBITDA margin stood at 47% in Q2 FY25. CARE Ratings' revenue from operations climbed 21% YoY to Rs 196.29 crore in the first half of 2024 (H1FY25). In H1FY25, the company's revenue from Ratings Business rose 19% YoY to Rs. 177.63 crore. Its revenue from Non-Ratings Business jumped 37% YoY to Rs. 18.66 crore. The board declared an interim dividend of Rs 7 per share for the second quarter of FY25. The record date is set on 5 November 2024. Commenting on the results for Q2 and H1FY25, Mehul Pandya, managing director & Group CEO of CareEdge, said: The company has shown good performance in ratings as well as non-rating businesses. Reflective of our commitment towards quality led growth, ratings business continued to show momentum in initial ratings of capital market instruments, securitisation and bank debt. In H1FY25, the contribution of non-ratings business to total consolidated revenue from operations has improved to 9.5% even as the ratings business witnessed a strong growth of 19%. We are proud to be the first rating agency from India to foray in the sovereign & global scale ratings, with the announcement of sovereign ratings of 39 countries at the launch event of CareEdge Global IFSC Ltd. Further, our step-down subsidiary in South Africa has also received the regulatory approval to offer credit ratings services, including sovereign ratings in that geography. CareEdge Africa and CareEdge Nepal reported robust growth in their business during the period. CareEdge ESG is on the path to be a catalyst for change towards sustainable future with the release of its first ESG rating recently. CareEdge Analytics and CareEdge Advisory continued to improve their performance during the period. Overall, CareEdge is well poised for continued success and growth, driven by our strategic pillars and an unyielding commitment to excellence. CARE Ratings is India's second-largest rating agency, with a credible track record of rating companies across diverse sectors and holding leadership positions in high-growth sectors such as BFSI and Infra. The wholly-owned subsidiaries of CareEdge Ratings are (I) CARE Analytics & Advisory (previously known as CARE Risk Solutions), (II) CARE ESG Ratings, (previously known as CARE Advisory Research and Training and (III) CareEdge Global IFSC. CareEdge Ratings' other international subsidiary entities include CARE Ratings (Africa) in Mauritius, CARE Ratings South Africa, and CARE Ratings Nepal. Powered by Capital Market - Live

1 month agoCapital Market - Live
Spotlight
CARE Ratings Ltd leads gainers in 'A' group

Piramal Pharma Ltd, Amber Enterprises India Ltd, Sona BLW Precision Forgings Ltd and Aster DM Healthcare Ltd are among the other gainers in the BSE's 'A' group today, 24 October 2024.CARE Ratings Ltd soared 20.00% to Rs 1409.15 at 11:47 IST. The stock was the biggest gainer in the BSE's 'A' group. On the BSE, 75822 shares were traded on the counter so far as against the average daily volumes of 5877 shares in the past one month. Piramal Pharma Ltd surged 13.89% to Rs 246.8. The stock was the second biggest gainer in 'A' group. On the BSE, 14.91 lakh shares were traded on the counter so far as against the average daily volumes of 3.36 lakh shares in the past one month. Amber Enterprises India Ltd spiked 10.20% to Rs 7052. The stock was the third biggest gainer in 'A' group. On the BSE, 53913 shares were traded on the counter so far as against the average daily volumes of 27338 shares in the past one month. Sona BLW Precision Forgings Ltd exploded 9.85% to Rs 705.75. The stock was the fourth biggest gainer in 'A' group. On the BSE, 2.65 lakh shares were traded on the counter so far as against the average daily volumes of 41065 shares in the past one month. Aster DM Healthcare Ltd advanced 7.30% to Rs 431.65. The stock was the fifth biggest gainer in 'A' group. On the BSE, 7.03 lakh shares were traded on the counter so far as against the average daily volumes of 39583 shares in the past one month. Powered by Capital Market - Live

1 month agoCapital Market - Live
Earnings
CARE Ratings consolidated net profit rises 31.05% in the September 2024 quarter

Net profit of CARE Ratings rose 31.05% to Rs 46.09 crore in the quarter ended September 2024 as against Rs 35.17 crore during the previous quarter ended September 2023. Sales rose 21.70% to Rs 117.37 crore in the quarter ended September 2024 as against Rs 96.44 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales117.3796.44 22 OPM %47.4743.46 - PBDT67.0952.69 27 PBT64.2350.06 28 NP46.0935.17 31 Powered by Capital Market - Live

1 month agoCapital Market - Live
Corporate
Board of CARE Ratings recommends interim dividend

CARE Ratings announced that the Board of Directors of the Company at its meeting held on 23 October 2024, inter alia, have recommended the interim dividend of Rs 7 per equity Share (i.e. 70%) , subject to the approval of the shareholders.Powered by Capital Market - Live

1 month agoCapital Market - Live
Corporate
CARE Ratings fixes record date for interim dividend

CARE Ratings has fixed 05 November 2024 as record date for the purpose of determining the eligibility of shareholders entitled for the payment of Interim Dividend for Financial Year 2024-25. Powered by Capital Market - Live

1 month agoCapital Market - Live
Corporate
Board of CARE Ratings recommends Interim Dividend

CARE Ratings announced that the Board of Directors of the Company at its meeting held on 23 October 2024, has recommended a Interim dividend of Rs.7 per share (i.e.70%), subject to the approval of the shareholders.Powered by Capital Market - Live

1 month agoCapital Market - Live
Corporate
CARE Ratings to table results

CARE Ratings will hold a meeting of the Board of Directors of the Company on 23 October 2024.Powered by Capital Market - Live

1 month agoCapital Market - Live
Earnings
CARE Ratings consolidated net profit rises 16.40% in the June 2024 quarter

Net profit of CARE Ratings rose 16.40% to Rs 20.73 crore in the quarter ended June 2024 as against Rs 17.81 crore during the previous quarter ended June 2023. Sales rose 18.82% to Rs 78.92 crore in the quarter ended June 2024 as against Rs 66.42 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales78.9266.42 19 OPM %27.6526.86 - PBDT33.2328.99 15 PBT30.4326.41 15 NP20.7317.81 16 Powered by Capital Market - Live

3 months agoCapital Market - Live

Tide turns: Deposit inflows outpace credit offtake

4 months agoEconomic Times
Corporate
CARE Ratings to declare Quarterly Result

CARE Ratings will hold a meeting of the Board of Directors of the Company on 7 August 2024.Powered by Capital Market - Live

4 months agoCapital Market - Live